Preventing and Managing Hair Loss on GLP-1 Medications Adequate protein intake is the single most effective prevention strategy during GLP-1 therapy
Using the wrong syringe type
3.4 Adverse events Three subjects experienced intermittent diarrhea, bloating and nausea before the initiation of semaglutide treatment (timepoint 1), but the symptoms were not severe enough to warrant discontinuation of metformin therapy
Individuals with type 2 diabetes treated with GLP-1s have demonstrated improvements in inflammatory signaling and mitochondrial redox balance, including reduced reactive oxygen species production, improved mitochondrial membrane potential, and increased oxygen consumption
They can also occur with depression, anxiety, sleep loss, thyroid disease, anemia, vitamin B12 deficiency, substance use, and other medications